# GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis

> **NCT01589523** · PHASE3 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 5 (actual)

## Conditions studied

- Bile Acid Synthesis Defect
- Inborn Error of Bile Acid Metabolism
- Inborn Error of Bile Acid Conjugation

## Interventions

- **DRUG:** Glycocholic Acid

## Key facts

- **NCT ID:** NCT01589523
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2019-01-22
- **Final completion:** 2019-01-22
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589523, "GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01589523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*